SCHEMBL17667994

SCHEMBL17667994

CC(CC(Cc1ccc(-c2ccccc2)cc1)NC(=O)c1ccc(F)c(O)c1F)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 12/20 0.60
▸ ACE P12821 2/20 0.60
▸ MMEL1 Q495T6 8/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18672831 1.00 MME (0.60) MMEACEMMEL1
SCHEMBL12317281 1.00 MME (0.60) MMEACEMMEL1
SCHEMBL12317398 0.89 MME (0.50) MMEACEMMEL1
SCHEMBL18672729 0.89 MME (0.50) MMEACEMMEL1
SCHEMBL18672674 0.89 MME (0.60) MMEACEMMEL1
SCHEMBL12317332 0.89 MME (0.60) MMEACEMMEL1
SCHEMBL18672691 0.83 MME (0.70) MMEACEMMEL1
SCHEMBL2705953 0.83 MME (0.70) MMEACEMMEL1
SCHEMBL12317275 0.81 MME (0.66) MMEACEMMEL1
SCHEMBL18672609 0.81 MME (0.66) MMEACEMMEL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3048100-A1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS Novartis AG (CH) 2016-07-27 — — EP disclosed
EP-2435402-B1 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS NOVARTIS AG (CH) 2016-04-13 — — EP disclosed
Send feedback